Nuvasive: Expect Big Things
NuVasive, a developer of surgical spine treatments, will offer $200 million convertible senior notes due 2013. The company estimates that the net proceeds from the […]
Sleep Solutions Secures $20.5 Million Of Equity Financing
Sleep Solutions (SSI) has secured $20.5 million in additional venture funding. The investment was led by the TPG Biotechnology II fund with participation from existing […]
Airborne Justice
Airborne is a dietary supplement and health formula which is said to help ward off harmful bacteria and germs, and help prevent the flu and […]
Gratuitous MRI Exemplifies Healthcare Waste
MRI Unnecessary for Diagnosing Osteoarthritis of the Knee A new study released today at the American Academy of Orthopaedic Surgeons’ annual meeting, found that patients […]
HEPA Filters Not Garbage, Study Says
Exposure to particulate matter is associated with risk of cardiovascular events, possibly through endothelial dysfunction, and indoor air may be most important, says a Danish-Swedish […]
STAAR Surgical Eyes Opportunity in China
Staar Surgical has received approval from China’s Food and Drug Administration to market its Visian Toric Implantable Collamer Lens for the treatment of nearsightedness and […]
Expanded Indications for Immunicon’s CellSearch
Immunicon’s CellSearch Circulating Tumor Cell (CTC) Kit has received FDA clearance as an aid in the monitoring of patients with metastatic prostate cancer. The kit […]
Exactech Expands Direct Distribution Abroad
Exactech, a developer of orthopedic implant devices, surgical instruments and biologic materials, announced yesterday the opening of a wholly-owned distribution subsidiary in Japan and the […]
New Competition for OraQuick Advance? Sublicense Agreement Expands Opportunity for Chembio’s Oral Fluid HIV Diagnostic
Chembio Diagnostics has acquired a worldwide, non-exclusive sublicense from Bio-Rad Laboratories. Under the terms of the agreement, Bio-Rad will permit Chembio to manufacture and market […]